Similar Jobs
See allSr. Scientist, Drug Safety (Pharmacovigilance)
Centessa Pharmaceuticals
US
Pharmacovigilance
Data Analysis
Regulatory Compliance
Director, Pharmacovigilance Sciences
EyePoint
US
Pharmacovigilance
FDA Regulations
ICH Guidelines
Scientist, Drug Safety (Pharmacovigilance)
Centessa Pharmaceuticals
US
Pharmacovigilance
Regulatory
Risk Assessment
Director, Pharmacovigilance Operations
Celcuity
Global
Pharmacovigilance
Regulatory Compliance
MS Office
Senior Specialist, Regulatory & PV Network
PrimeVigilance
Global
GVP
Responsibilities:
- Support Safety Physicians with safety-related tasks across commercial products and products in clinical development.
- Acquire and contribute to the knowledge of the relevant drug class and/or competitor safety issues.
- Contribute to safety risk management including but not limited to routine review of safety data and pertinent scientific literature articles.
Qualifications:
- A relevant postgraduate qualification (e.g., MSc or equivalence in healthcare or in a Life sciences discipline, PhD is a plus or other post-graduate health professional qualifications).
- Five or more (5+) years of drug development experience in the pharmaceutical or related industry with at least three (3) years of experience in drug safety/pharmacovigilance.
- Must have at least two (2) years’ data management and analysis experience;
About Us:
- Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications.
- Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings.
- Celcuity is an Equal-Opportunity Employer.
Celcuity
Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth.